A recombinant protein corresponding to the human prion protein domain encompassing residues 90 -231 (huPrP(90 -231)) was expressed in Escherichia coli in a soluble form and purified to homogeneity. Spectroscopic data indicate that the conformational properties and the folding pathway of huPrP(90 -231) are strongly pH-dependent. Acidic pH induces a dramatic increase in the exposure of hydrophobic patches on the surface of the protein. At pH between 7 and 5, the unfolding of hPrP(90 -231) in guanidine hydrochloride occurs as a two-state transition. This contrasts with the unfolding curves at lower pH values, which indicate a three-state transition, with the presence of a stable protein folding intermediate. While the secondary structure of the native huPrP(90 -231) is largely ␣-helical, the stable intermediate is rich in -sheet structure. These findings have important implications for understanding the initial events on the pathway toward the conversion of the normal into the pathological forms of prion protein.Prion diseases comprise a group of transmissible neurodegenerative disorders. The best known animal forms of the disease are scrapie and bovine spongiform encephalopathy; the human versions include kuru, Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker disease, and fatal familial insomnia (1-4). All of these disorders are characterized by cerebral accumulation of an abnormal protein, designated PrP res , which has a strong tendency to aggregate into insoluble fibrils. According to the "protein only hypothesis" (5, 6), PrP res constitutes the sole component of the infectious pathogen responsible for the transmission of prion disease.PrP res is derived from a host-encoded glycoprotein, the prion protein (PrP). 1 The transition between the cellular form of PrP, designated PrP C , and PrP res occurs by a post-translational mechanism and appears to take place without any detectable covalent modifications to the protein molecule (7). One of the main characteristics distinguishing PrP C from PrP res is the resistance of the latter to proteolytic digestion (8, 9). Furthermore, recent spectroscopic studies indicate that the two isoforms have profoundly different conformation: while the secondary structure of PrP C consists largely of ␣-helices (10), PrP res appears to be rich in -sheet structure (10 -13). In line with these observations, the current view is that prion diseases may be classified as disorders resulting from abnormal protein folding and that the key event in the pathogenic process is the transition between the "benign" conformation of PrP C and the "pathological" conformation of PrP res . It is believed that the propagation of the disease can be described according to nucleation-dependent polymerization and/or template-assisted models (6, 14 -17). However, the molecular mechanism and potential intermediate forms of PrP underlying the conformational transition between the normal and pathogenic isoforms of the protein remain unknown.Recent studies have provided an insight into the three-dimens...